11.06.2014 • News • Bayer • Bristol-Myers Squibb (BMS) • Dede Willams

Dieter Weinand Named to Head Bayer HealthCare Pharmaceuticals

Effective August 1, 2014, Dieter Weinand will become president of Bayer HealthCare Pharmaceuticals and at the same time join the Executive Committee of Bayer HealthCare. He replaces Andreas Fibig, who will leave Bayer on September 1, 2014, to become CEO of International Flavours and Fragrances.

The 53-year-old native of Boppard, Germany is currently president global commercialization & Portfolio management at Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey, USA. He has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry, including stints at Pfizer and Bristol-Myers Squibb.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Top-Feature